Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.

Jinmin HanChengrui FuBaosheng Li

Published in: Radiation oncology (London, England) (2021)

CHT/TRT could improve survival for ES-SCLC patients. TRT performed within 6 cycles of CHT and hyperfractionated radiotherapy (45 Gy in 30 fractions) may be a feasible treatment scheme for ES-SCLC patients.

Keyphrases

end stage renal disease
small cell lung cancer
ejection fraction
newly diagnosed
chronic kidney disease
early stage
peritoneal dialysis
prognostic factors
radiation therapy
squamous cell carcinoma
radiation induced
spinal cord injury
brain metastases